Document Detail


Changing dietary practices in phenylketonuria.
MedLine Citation:
PMID:  20112594     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In recent years, there has been much focus on research on non-dietary treatments in phenylketonuria (PKU). However, diet is likely to remain the major treatment for many years to come, since it has continued to be developed and consistent improvements have occurred. For example, with protein substitute, studies have tried to define the optimal dose and timing of intake; changes in palatability and presentation appear to have led to the long-term maintenance of acceptable blood phenylalanine control in teenage patients, and the low phenylalanine protein source glycomacropeptide is being considered as an alternative source to non-phenylalanine amino acids. Some countries are now adopting a simpler approach to dietary management, allowing a wider range of lower low phenylalanine foods without measurement, in combination with controlled phenylalanine exchange systems. Patients with PKU who are partially responsive to sapropterin dihydrochloride still require some dietary treatment. Long-term studies are required for examining the combined use of sapropterin dihydrochloride and diet to determine its impact on nutritional adequacy, growth, and blood phenylalanine variability. Generally, whether diet is used alone or in combination with sapropterin dihydrochloride, its true impact on quality of life and lifestyle should be investigated. Overall, it is likely we will continue to see many changes in the dietary treatment in the next five years, and hopefully this will lead to a better outcome for patients.
Authors:
Anita MacDonald; H?lya G?kmen-Ozel; Anne Daly
Related Documents :
10584974 - Animal models of the ketogenic diet: what have we learned, what can we learn?
15526964 - Lack of long-term histopathologic changes in brain and skeletal muscle of mice treated ...
347364 - Effects of diet and behavior therapy on social and motor behavior of retarded phenylket...
16940764 - Neuroprotective and disease-modifying effects of the ketogenic diet.
21512794 - Weight loss is associated with improved endothelial dysfunction via nox2-generated oxid...
186664 - The effect of changes in dietary sodium on lung and serum antiotensin-i-converting enzy...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Turkish journal of pediatrics     Volume:  51     ISSN:  0041-4301     ISO Abbreviation:  Turk. J. Pediatr.     Publication Date:    2009 Sep-Oct
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-02-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417505     Medline TA:  Turk J Pediatr     Country:  Turkey    
Other Details:
Languages:  eng     Pagination:  409-15     Citation Subset:  IM    
Affiliation:
Birmingham Children's Hospital, Birmingham, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biopterin / analogs & derivatives,  therapeutic use
Combined Modality Therapy / methods
Diet, Protein-Restricted*
Humans
Nutritional Status
Phenylalanine / blood
Phenylketonurias / diet therapy*,  drug therapy
Chemical
Reg. No./Substance:
17528-72-2/5,6,7,8-tetrahydrobiopterin; 22150-76-1/Biopterin; 63-91-2/Phenylalanine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Advances of screw internal fixation for the treatment of distal tibiofibular syndesmosis injuries
Next Document:  Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical sta...